lines exhibit an active phosphorylated form of Akt
Kinase. Therefore, the development of novel and
highly efficient methods to construct these fused angular
heterocyclic architectures is highly desirable for drug
discovery.
Scheme 1. Different Pathways for the 4-Substituted Pyrrolo[1,2-a]-
quinoxalines Formation
Many methods for syntheses of 4,5-dihydropyrrolo-
[1,2-a]quinoxalines,6 pyrrolo[1,2-a]quinoxalin-4-ones,7 and
unsubstitued pyrrolo[1,2-a]quinoxalines8 have been devel-
oped; however, to the best of our knowledge, only a few
synthetic procedures have been reported for fused aromatic
pyrrolo[1,2-a]quinoxalines substituted in C-4 by aryl or
alkyl groups. As shown in Scheme 1, all of the reported
4-substituted pyrrolo[1,2-a]quinoxaline derivatives were ob-
tained by the reduction of the 1-(2-nitrophenyl)pyrroles to
provide the amino intermediates. The main synthetic meth-
od utilized various alkyl- and aryl-acid chlorides with
the amino group to obtain the corresponding acetamides.
Subsequently, 4-substituted pyrrolo[1,2-a]quinoxalines
were prepared by intramolecular cyclization of theses
amides according to the BischlerÀNapieralski reaction.9
The other approach involved the reaction between the
corresponding 1-(2-aminophenyl)pyrroles with aldehydes
in an acidic medium followed by oxidation of the 4,5-
dihydropyrrolo[1,2-a]quinoxaline intermediates.10 More
recently, a modified PictetÀSpengler reaction using benzo-
triazole methodology reported the one-pot synthesis of
these fused aromatic heterocycles.11 This is the firstexample
of constructing 4-aryl pyrrolo[1,2-a]quinoxalines between
aromatic aldehydes and the amino intermediates. In all
cases, these multistep syntheses led to modest overall yields
using volatile and environmentally toxic reagents such as
aliphatic aldehydes. Therefore, the use of alcohols with
nitroarenes as starting materials to form a direct CÀN bond
is highly attractive, and great progress has been made during
the past decade to develop environmentally friendly pro-
cesses toward this subject.12
Until now, whereas aryl nitro reduction with iron pow-
der as a reducing agent has already been studied, there are
only a few reports of using cheap and less toxic iron
catalysts for the oxidation of alcohols to carbonyls. In
the literature, the oxidation catalyzed by ferrous ions and
hydrogen peroxide (the Fenton reaction) has been care-
fully investigated,13 unlike oxidations with ferric ions
which have received considerably less attention. More
recently, a few methods have been developed using iron-
(III)ÀSchiff baseÀtriphenylphosphine complexes,14 iron-
(III) bromide,15 iron(III) nitrate,16 and iron(III) porphyrin
and nonporphyrin complexes,17 but all of the reagents
need the presence of hydrogen peroxide (or a peroxide) as
a reagent.
This new method provided a route for the construction
of a variety of substituted pyrrolo[1,2-a]quinoxaline deri-
vatives via iron-mediated aryl nitro reduction and aerobic
oxidation of alcohols in the one-pot procedure. Moreover,
we have extended this reaction to novel pyrido[3,2-e]-
pyrrolo[1,2-a]pyrazines.
Performed inusualreduction conditions (3 equivofiron,
6 equiv of HCl), the reaction led mainly to the expected
amino 3a besides a trace of pyrrolo[1,2-a]quinoxaline 2a
(Table 1, entry 1). In order to understand and optimize this
surprising result, we decided to reinvestigate the experi-
mental conditions to obtain the tricyclic aromatic skeleton
in one pot. When a large excess of iron powder (9 equiv)
and HCl 12 M (11 equiv) were used, only the desired
compound 2a was observed (74%) and no trace of the
amino compound 3awasidentified(entry 2). The best yield
was obtained with the same equivalents of iron and
chlorhydric acid in refluxing ethanol (80%) (entry 3). It
should be noted that when more than 14 equiv of iron, the
yield decreased to 60% because of the complex mixture of
Herein, we reported the first one-pot synthesis of 4-sub-
stituted pyrrolo[1,2-a]quinoxalines from 1-(2-nitrophenyl)-
pyrrole derivatives and various alcohols in redox conditions.
In this process, alcohols were oxidized in situ from a
nitroarene reduction step and no external oxidant reagent
was added to the reaction mixture.
(6) (a) Liu, G.; Zhou, Y.; Lin, D.; Wang, J.; Zhang, L.; Jiang, H.; Liu,
H. ACS Comb. Sci. 2011, 13, 209–213. (b) Xu, H.; Fan, L. Eur. J. Med.
Chem. 2011, 46, 1919–1925.
(7) Qiliang Yuan, D. M. J. Org. Chem. 2008, 73, 5159–62.
(8) Reeves, J. T.; Fandrick, D. R.; Tan, Z.; Song, J. J.; Lee, H.; Yee,
N. K.; Senanayake, C. H. J. Org. Chem. 2010, 75, 992–994.
(9) (a) Cheeseman, G. W. H.; Tuck, B. J. Chem. Soc. (C) 1966, 852–
855. (b) Guillon, J.; Forfar, I.; Mamani-Matsuda, M.; Desplat, V.;
ꢁ
ꢀ
Saliege, M.; Thiolat, D.; Massip, S.; Tabourier, A.; Leger, J.-M.;
Dufaure, B.; Haumont, G.; Jarry, C.; Mossalayi, D. Bioorg. Med. Chem.
2007, 15, 194–210. (c) Kalinin, A. A.; Mamedov, V. A. Chem. Hetero-
cycl. Compd. 2011, 46, 1423–1442. (d) Lancelot, J.-C.; Rault, S.;
Laduree, D.; Robba, M. Chem. Pharm. Bull. 1985, 33, 2798–2802.
(10) Kaminskii, V. A.; Moskovkina, T. V.; Borodina, S. V. Chem.
Heterocycl. Compd. 1992, 28, 97–100.
(13) (a) Walling, C. Acc. Chem. Res. 1998, 31, 155–157. (b) MacFaul,
P. A.; Wayner, D. D. M.; Ingold, K. U. Acc. Chem. Res. 1998, 31, 159–
162.
(14) Rani, S.; Bhat, B. R. Tetrahedron Lett. 2010, 51, 6403–6405.
(15) Martın, S. E.; Garrone, A. Tetrahedron Lett. 2003, 44, 549–552.
´
(16) Namboodiri, V. V.; Polshettiwar, V.; Varma, R. S. Tetrahedron
Lett. 2007, 48, 8839–8842.
(17) Han, J. H.; Yoo, S.-K.; Seo, J. S.; Hong, S. J.; Kim, S. K.; Kim,
C. Dalton Trans. 2005, 402.
(11) Verma, A. K.; Jha, R. R.; Sankar, V. K.; Aggarwal, T.; Singh,
R. P.; Chandra, R. Eur. J. Org. Chem. 2011, 2011, 6998–7010.
(12) (a) Feng, C.; Liu, Y.; Peng, S.; Shuai, Q.; Deng, G.; Li, C.-J. Org.
Lett. 2010, 12, 4888–4891. (b) Xie, Y.; Liu, S.; Liu, Y.; Wen, Y.; Deng,
G.-J. Org. Lett. 2012, 14, 1692–1695. (c) Wu, M.; Hu, X.; Liu, J.; Liao,
Y.; Deng, G.-J. Org. Lett. 2012, 14, 2722–2725.
Org. Lett., Vol. 14, No. 18, 2012
4755